A Florida surgeon has performed the first telerobotic operation between two US hospitals, removing the prostate of a man with ...

A phase 3 PROTEUS substudy published in European Urology reports that perioperative apalutamide plus hormone therapy around ...

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...

An analysis of United States registry and health system data shows low-risk prostate cancer is being diagnosed less often and ...

New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ...

A doctor in Florida performed a medical first on Sunday, using a robotic telesurgery system to perform a surgery at a ...

The optimal strategy for treating newly diagnosed high-risk prostate cancer remains unclear. More specifically, do these patients benefit more from radical prostatectomy or a radiotherapy-based ...

There will be approximately 299,010 new cases of prostate cancer diagnosed in 2024, according to the American Cancer Society. Treatments vary, including chemotherapy, hormone therapy, ablative therapy ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Israeli Prime Minister Benjamin Netanyahu, 75, had his prostate removed ...

Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of apalutamide plus androgen deprivation therapy (ADT), given ...